References
- Excler JL, Saville M, Berkley S, Kim JH. Vaccine development for emerging infectious diseases. Nat Med 2021;27:591-600. https://doi.org/10.1038/s41591-021-01301-0
- World Health Organization. Global vaccine market report. Geneva: World Health Organization; 2020.
- Patel SP, Patel GS, Suthar JV. Inside the story about the research and development of COVID-19 vaccines. Clin Exp Vaccine Res 2021;10:154-70. https://doi.org/10.7774/cevr.2021.10.2.154
- Li L, Honda-Okubo Y, Huang Y, et al. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection. Vaccine 2021;39:5940-53. https://doi.org/10.1016/j.vaccine.2021.07.087
- Han S. Clinical vaccine development. Clin Exp Vaccine Res 2015;4:46-53. https://doi.org/10.7774/cevr.2015.4.1.46
- Zhang M, Liang Y, Yu D, et al. A systematic review of vaccine breakthrough infections by SARS-CoV-2 delta variant. Int J Biol Sci 2022;18:889-900. https://doi.org/10.7150/ijbs.68973
- Crick JM, Crick D. Coopetition and COVID-19: collaborative business-to-business marketing strategies in a pandemic crisis. Ind Mark Manag 2020;88:206-13. https://doi.org/10.1016/j.indmarman.2020.05.016
- Krasilnikova A. Brief overview of the currently available COVID-19 vaccines. J Clin Health Sci 2022;7:5-24. https://doi.org/10.24191/jchs.v7i1.14658
- Kandimalla R, Chakraborty P, Vallamkondu J, et al. Counting on COVID-19 vaccine: insights into the current strategies, progress and future challenges. Biomedicines 2021;9:1740.
- Kudlay D, Svistunov A. COVID-19 vaccines: an overview of different platforms. Bioengineering (Basel) 2022;9:72.
- Razi Vaccine and Serum Research Institute. Razi Vaccine and Serum Research Institute website [Internet]. Karaj: Razi Vaccine and Serum Research Institute; 2022 [cited 2022 Jul 10]. Available from: https://english.rvsri.ac.ir/portal/home/?239735/Home.
- Maslehat S, Esmaeili Rastaghi AR, Siavashi MR, Mostafavi E. In honor of Dr. Mehdi Assmar, a distinguished researcher at the Pasteur Institute of Iran. J Res Hist Med 2021;10:81-94.
- Iranbio. Iranbio website [Internet]. Tehran: Iranbio; 2022 [cited 2022 Jul 10]. Available: https://iranbio.info/en.
- Heidarzadeh A, Moridani MA, Khoshmanesh S, Kazemi S, Hajiaghabozorgi M, Karami M. Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test negative case-control study. Int J Infect Dis 2022 Dec 23 [Epub]. https://doi.org/10.1016/j.ijid.2022.12.024
- Mohraz M, Salehi M, Tabarsi P, et al. Safety and immunogenicity of an inactivated virus particle vaccine for SARSCoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults. BMJ Open 2022;12:e056872.
- Majidpour M, Saber A, Elahi S, Shayan A, Khorasani SM. Technological catch-up in the biopharmaceutical sector: evidence from Iran. Technol Soc 2021;67:101695.
- Tabarsi P, Anjidani N, Shahpari R, et al. Safety and immunogenicity of SpikoGen, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations. Clin Microbiol Infect 2022;28:1263-71. https://doi.org/10.1016/j.cmi.2022.04.004
- Eroglu B, Nuwarda RF, Ramzan I, Kayser V. A narrative review of COVID-19 vaccines. Vaccines (Basel) 2021;10:62.
- Ghasemi S, Naderi Saffar K, Ebrahimi F, et al. Development of inactivated FAKHRAVAC vaccine against SARSCoV-2 virus: preclinical study in animal models. Vaccines (Basel) 2021;9:1271.
- Perez C. Technological revolutions and financial capital. Cheltenham: Edward Elgar Publishing; 2003.
- Tasnim News Agency. Medical news, financial support of Iranian COVID-19 vaccine development [Internet]. Tehran: Tasnim News Agency; 2022 [cited 2022 Jul 10]. Available from: https://tn.ai/2599659.
- World Health Organization. Increasing access to vaccines through technology transfer and local production. Geneva: World Health Organization; 2011.
- Al-Mistarehi AH, Kheirallah KA, Yassin A, et al. Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country. Clin Exp Vaccine Res 2021;10:171-82. https://doi.org/10.7774/cevr.2021.10.2.171